298 related articles for article (PubMed ID: 11799157)
1. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
Yang OO; Nguyen PT; Kalams SA; Dorfman T; Göttlinger HG; Stewart S; Chen IS; Threlkeld S; Walker BD
J Virol; 2002 Feb; 76(4):1626-31. PubMed ID: 11799157
[TBL] [Abstract][Full Text] [Related]
2. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
Tomiyama H; Akari H; Adachi A; Takiguchi M
J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
[TBL] [Abstract][Full Text] [Related]
3. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
6. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
Ali A; Ng HL; Dagarag MD; Yang OO
Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
[TBL] [Abstract][Full Text] [Related]
7. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
da Silva J; Hughes AL
Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
[TBL] [Abstract][Full Text] [Related]
8. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
[TBL] [Abstract][Full Text] [Related]
9. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
10. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
Robertson MN; Buseyne F; Schwartz O; Rivière Y
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
[TBL] [Abstract][Full Text] [Related]
11. Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.
Nixon DF; Douek D; Kuebler PJ; Jin X; Vesanen M; Bonhoeffer S; Cao Y; Koup RA; Ho DD; Markowitz M
Immunol Lett; 1999 Mar; 66(1-3):219-28. PubMed ID: 10203058
[TBL] [Abstract][Full Text] [Related]
12. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects.
Chassin D; Andrieu M; Cohen W; Culmann-Penciolelli B; Ostankovitch M; Hanau D; Guillet JG
Eur J Immunol; 1999 Jan; 29(1):196-202. PubMed ID: 9933101
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.
Noviello CM; Pond SL; Lewis MJ; Richman DD; Pillai SK; Yang OO; Little SJ; Smith DM; Guatelli JC
J Virol; 2007 May; 81(9):4776-86. PubMed ID: 17329339
[TBL] [Abstract][Full Text] [Related]
16. HIV's evasion of the cellular immune response.
Collins KL; Baltimore D
Immunol Rev; 1999 Apr; 168():65-74. PubMed ID: 10399065
[TBL] [Abstract][Full Text] [Related]
17. Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells.
Shapira-Nahor O; Maayan S; Peden KW; Rabinowitz R; Schlesinger M; Alian A; Panet A
Virology; 2002 Nov; 303(1):138-45. PubMed ID: 12482665
[TBL] [Abstract][Full Text] [Related]
18. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S
J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef.
Guillon C; van Baalen CA; Boers PH; Verschuren EJ; Gruters RA; Osterhaus AD
J Virol Methods; 2002 Jan; 99(1-2):115-21. PubMed ID: 11684309
[TBL] [Abstract][Full Text] [Related]
20. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.
Dong T; Stewart-Jones G; Chen N; Easterbrook P; Xu X; Papagno L; Appay V; Weekes M; Conlon C; Spina C; Little S; Screaton G; van der Merwe A; Richman DD; McMichael AJ; Jones EY; Rowland-Jones SL
J Exp Med; 2004 Dec; 200(12):1547-57. PubMed ID: 15596521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
